The medical director of the Ohio State Sleep Medicine Institute provided insight on areas within sleep disorder care that need improvement, including the diagnostic process.
Asim Roy, MD
Advertisement
Articles by Asim Roy, MD
The medical director of the Ohio State Sleep Medicine Institute discussed the effect of FT218 in treating narcolepsy regardless of stimulant use, as well as its weight-related benefits it brings.
The medical director of the Ohio State Sleep Medicine Institute detailed the progress made within the sleep disorder field in recent years and where it can turn to next.
Advertisement
Latest Updated Articles
Future Areas of Progress for Sleep Disorder Care: Asim Roy, MDPublished: June 17th 2021 | Updated:
FT218’s Effect on BMI Regardless of Stimulant Use: Asim Roy, MDPublished: June 18th 2021 | Updated:
Greatest Unmet Needs in Sleep Disorder Care: Asim Roy, MDPublished: June 23rd 2021 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Subcutaneous Efgartigimod Shows Efficacy in Phase 2 ALKIVIA, Phase 3 ADAPT SERON Trials
2
Open-Label Extension Highlights Continued Therapeutic Benefit of Nipocalimab in Patients Transitioning From Placebo
3
B-Cell Modulator Obexelimab Shows Pronounced Relapse Reduction in Phase 2 MoonStone Trial
4
Independent Adjudication Committee Helps Facilitate Accurate Enrollment of Phase 2/3 ARISE Trial of Nipocalimab
5
